West Pharmaceutical Services

Yahoo Finance • 3 days ago

WEST PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In West Pharmaceuticals (WST) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in West between Febru... Full story

Yahoo Finance • last month

Should You Be Optimistic on West Pharmaceutical (WST)?

Brown Advisory, an investment management company, released its “Brown Advisory Large-Cap Growth Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Brown Advisory Large-Cap Growth strategy has sh... Full story

Yahoo Finance • 2 months ago

Nilesh Shah joins Illumina as Head of Region, AMEA

SINGAPORE, Aug. 19, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment of Nilesh Shah as Head of Region, AMEA, effective immediately.Nilesh Sha... Full story

Yahoo Finance • 3 months ago

KeyBanc maintains Overweight rating on West Pharmaceutical stock

Investing.com - KeyBanc Capital Markets maintained its Overweight rating and $325.00 price target on West Pharmaceutical (NYSE:WST) following the company’s quarterly results. According to InvestingPro data, the stock has seen strong moment... Full story

Yahoo Finance • 3 months ago

West Pharmaceutical rises on upbeat results, guidance raise

[Wall Street New York City] aluxum/E+ via Getty Images Shares of West Pharmaceutical (NYSE:WST [https://seekingalpha.com/symbol/WST]) jumped on Thursday after the company reported its second-quarter results above estimates and raised full... Full story

Yahoo Finance • 3 months ago

Earnings Reports Leave Equities Mixed Ahead of Trump's Fed Visit

US benchmark equity indexes were mixed intraday as markets evaluated the latest corporate earnings a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

Why Are West Pharmaceutical Services (WST) Shares Soaring Today

What Happened? Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 22.9% in the afternoon session after the company reported strong second-quarter 2025 financial results and raised its full-year outlook.... Full story

Yahoo Finance • 3 months ago

West Pharma Q2 Profit Rises; Lifts FY25 Outlook; Stock Up In Pre-market

(RTTNews) - West Pharmaceutical Services, Inc. (WST), a designer and manufacturer of injectable pharmaceutical packaging and delivery systems, on Thursday announced that net income increased in the second quarter compared with the previous... Full story

Yahoo Finance • 3 months ago

West Pharmaceutical raises dividend by 4.8% to $0.22

* West Pharmaceutical (NYSE:WST [https://seekingalpha.com/symbol/WST]) declares $0.22/share quarterly dividend [https://seekingalpha.com/pr/20176262-west-announces-second-quarter-2025-results-and-fourth-quarter-2025-dividend-updates-full... Full story

Yahoo Finance • 3 months ago

Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks

West Pharmaceutical Services Inc. (NYSE:WST) is one of the most oversold S&P 500 stocks so far in 2025. On June 24, Barclays analyst Luke Sergott began coverage on West Pharmaceutical Services (WST) with an Equal Weight rating and a price... Full story

Yahoo Finance • 3 months ago

West Pharmaceutical Services taps Robert McMahon as CFO

* West Pharmaceutical Services (NYSE:WST [https://seekingalpha.com/symbol/WST]) has appointed Robert McMahon as the company's new chief financial officer, effective August 4, 2025. * Prior to this appointment, McMahon served as chief f... Full story

Yahoo Finance • 3 months ago

West pharmaceutical services appoints Robert McMahon as new CFO

EXTON, Pa. - West Pharmaceutical Services, Inc. (NYSE:WST), a healthcare company with a market capitalization of $15.15 billion and an overall "GOOD" financial health rating according to InvestingPro, announced today the appointment of Rob... Full story

Yahoo Finance • 3 months ago

Is West Pharmaceutical Services (WST) a Great Business Unfairly Sold Off by the Market?

Brasada Capital Management, an investment management company, released its Q2 2025 investor letter. A copy of the letter can be downloaded here.  This year’s financial markets have been highly volatile, with the S&P 500 experiencing a 6.20... Full story

Yahoo Finance • 3 months ago

Notable healthcare headlines for the week: Trump’s tariff threat, Merck, UnitedHealth and Moderna in focus

Wall Street’s major averages ended slightly lower last week, after posting back-to-back record closes as market participants juggled Trump's tariff announcements against a healthy appetite for technology and growth stocks. Week-to-date, t... Full story

Yahoo Finance • 3 months ago

WEST ALERT: Bragar Eagel & Squire, P.C. is Investigating West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against West Pharmaceutical Services, Inc. (NYSE:WST) on behalf of long-term... Full story

Yahoo Finance • 3 months ago

West Pharmaceutical Services, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights – WST

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are en... Full story

Yahoo Finance • 3 months ago

DEADLINE ALERT for WST, DMRC, CODI, and ELV: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, July 07, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story

Yahoo Finance • 3 months ago

WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services,... Full story

Yahoo Finance • 3 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In West To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in West... Full story

Yahoo Finance • 3 months ago

Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights – WST

NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS D... Full story